RxDoctor Payments DataLook up a doctor →

Jennifer Irwin, PA

Medical · Indianapolis, INNPI 1043309461

Payments from drug & device makers

$34,267in general payments, 2019–2025

Across 1,420 payments — averaging $24.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$6K
  • AbbVie$4K
  • Livanova USA, Inc.$4K
  • UCB, Inc.$2K
  • Pfizer$1K
  • Jazz Pharmaceuticals Inc.$1K
  • plus $15K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.90$5,843
AbbVie(2 entities)222$3,944
Livanova USA, Inc.24$3,754
UCB, Inc.161$2,471
Pfizer91$1,303
Jazz Pharmaceuticals Inc.46$1,284
SK Life Science, Inc.55$1,133
Novartis49$1,132
Biohaven Pharmaceuticals, Inc.49$889
Eisai Inc.43$839
Biogen35$779
Lilly USA, LLC53$742
Lundbeck LLC22$731
Neurocrine Biosciences, Inc.37$671
Amgen(2 entities)22$643
Neurelis, Inc.25$642
Catalyst Pharmaceuticals, Inc.29$612
AstraZeneca(2 entities)27$532
Biohaven Pharmaceutical Holding Company Ltd.53$493
Teva Pharmaceuticals USA, Inc.35$472
Argenx US, Inc.26$411
MDD US Operations, LLC17$408
Acadia Pharmaceuticals Inc15$351
TG Therapeutics, Inc.16$347
Sanofi6$320
Amneal Pharmaceuticals LLC16$310
Axsome Therapeutics, Inc.17$217
Takeda Pharmaceuticals U.S.A., Inc.8$213
Supernus Pharmaceuticals, Inc.12$191
Zogenix Inc.3$186
Otsuka America Pharmaceutical, Inc.13$184
Greenwich Biosciences, Inc.5$167
CSL Behring7$167
Johnson & Johnson7$155
Alnylam Pharmaceuticals Inc.7$153
Harmony Biosciences LLC4$117
Banner Life Sciences, LLC6$115
Neuropace, Inc.1$93
Bristol Myers Squibb4$87
Genentech USA, Inc.4$79
Tanabe Pharma America, Inc.3$71
Mallinckrodt Hospital Products Inc.3$65
Acorda Therapeutics, Inc4$64
Medtronic4$63
Grifols USA, LLC3$63
Aquestive Therapeutics, Inc.4$63
Cycle Pharmaceuticals Inc3$59
Ipsen Biopharmaceuticals, Inc4$59
PTC Therapeutics, Inc.2$53
Avanir Pharmaceuticals, Inc.3$50
GRT US Holding, Inc.2$42
Impel Pharmaceuticals Inc.2$38
Avadel CNS Pharmaceuticals, LLC2$36
Tersera Therapeutics LLC2$34
Merz Pharmaceuticals, LLC2$32
Vanda Pharmaceuticals Inc.1$29
Abbott1$24
Sumitomo Pharma America, Inc.1$24
Upsher-smith Laboratories LLC1$24
Resmed Corp1$22

How this compares

$34,267 in reported general payments places this provider in the 95th percentile of 273 medical providers in Indiana.

See all medical providers in Indiana →

Medicare billing

Part B allowed, 2024
$9,360
Medicare patients
23
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Indianapolis

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →